EUVIMEDEUVIMED entdecken
Crossref

Pathophysiology of Beta-Thalassaemia: (Part – 1) [Ineffective Erythropoiesis]

Ne Win

Myanmar Medical Journal · 2025

DOI: 10.64455/xmma0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Myanmar Medical Journal, 2025. Verfasst von Ne Win. Die Arbeit nennt 131 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thalassaemia is an inherited haemoglobin disorder characterized by reduced or absent globin chain synthesis, resulting in variable clinical phenotypes from severe chronic anaemia requiring lifelong transfusion and iron chelating therapy to asymptomatic indivi- duals. β-thalassaemia has a broad clinical spectrum, and traditionally has been classified as thalassaemia major (TM), thalassaemia intermedia (TI), and thalassaemia minor. Acc- ording to RBC/Blood transfusions requirement, β-thalassaemia is classified as either transfusion-dependent thalassaemia (TDT) or non-transfusion-dependent thalassaemia (NTDT). Patients with TDT need life-long regular transfusions for survival from early child- hood, while patients with NTDT do not need life-long regular transfusions for survival.

Zitieren

APA

Win, N. (2025). Pathophysiology of Beta-Thalassaemia: (Part – 1) [Ineffective Erythropoiesis]. Myanmar Medical Journal. https://doi.org/10.64455/xmma0004

Vancouver

Win N. Pathophysiology of Beta-Thalassaemia: (Part – 1) [Ineffective Erythropoiesis]. Myanmar Medical Journal. 2025. doi:10.64455/xmma0004

BibTeX
@article{Win2025,
  author = {Win, Ne},
  title = {Pathophysiology of Beta-Thalassaemia: (Part – 1) [Ineffective Erythropoiesis]},
  journal = {Myanmar Medical Journal},
  year = {2025},
  doi = {10.64455/xmma0004}
}
Kostenlos starten →